Genetic Disorders
Conditions
Keywords
Multiple genetic conditions will be studied
Brief summary
The objective of this study is to validate the performance characteristics of the GeneTrait CGH Microarray System DX. Reproducibility among sites, lots, and operators will be evaluated.
Interventions
None listed
Sponsors
Abbott Molecular
Study design
Observational model
DEFINED_POPULATION
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Must be able to donate at least 10 mL of whole blood * Must be able to provide consent, or parental consent and patient assent (if applicable) * Must be currently followed as a patient of a genetic clinic or counselor at one of the recruiting sites * Must have at least one chromosomal change that is detectable by the GeneTrait CGH Microarray System DX as determined by karyotype and/or fluorescence in situ hybridization (FISH) analysis (within any of the 73 critical regions)
Exclusion criteria
* Unable to donate at least 10 mL of whole blood * Unable to provide consent, or parental consent and patient assent (if applicable) * Not currently followed as a patient of a genetic clinic or counselor at one of the recruiting sites * Does not have at least one chromosomal change that is detectable by the GeneTrait CGH Microarray System DX as determined by karyotype and/or FISH analysis (within any of the 73 critical regions)
Contacts
Primary ContactLynda Hague
Backup ContactAndrew Hiar
Outcome results
None listed